Tomorrow! Webinar: Trends in Peptides and Oligonucleotides - Choosing a Partner CDMO

[CPhI China]

 View webversion (https://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYGJm8D.H1tTA3ML0f5GthaGxsZkBAAA63) 
 (https://www.pharmasources.com/zt/etradeseason2022/bachem?utm_source=etrade2022-bachem&utm_medium=online-EDM&utm_campaign=enedmbachem0420)
April

21

4 p.m. UTC+8 
On-demand Webinar
Trends in Peptides and Oligonucleotides - Choosing a Partner CDMO

Sponsored by Bachem

Peptide and oligonucleotide drugs are versatile therapeutics with a growing range of applications and many similarities in terms of manufacturing and regulation. New formulations often increase the complexity of the products and demand innovative solutions. Partnering with an experienced CDMO can support drug developers’ manufacturing needs and allow them to focus on the core of their developments. 
 
Topic HighlightsMarkets Trends in Peptides and OligonucleotidesEvolution of Therapeutic Fields and Methods Importance of Large-scale Production of Peptides and OligonucleotidesHow can CDMOs bring your products to the market more efficiently? 
Register for Free (https://www.pharmasources.com/zt/etradeseason2022/bachem?utm_source=etrade2022-bachem&utm_medium=online-EDM&utm_campaign=enedmbachem0420)
Meet the Speaker and Moderator
​​​​​​

Tycho Leifels, Ph.D.
Group Leader Product Management
Bachem

Daniel Grotzky, Ph.D.
Head of Group Communication
Bachem

Learn More (https://www.pharmasources.com/zt/etradeseason2022/bachem?utm_source=etrade2022-bachem&utm_medium=online-EDM&utm_campaign=enedmbachem0420)
More Sessions to Follow...
 

The Future of Biomanufacturing: Capacity, Capability and Careers

March 31   4:00 PM UTC+8
Watch On-demand (https://www.pharmasources.com/zt/etradeseason2022/bioprocessing?utm_source=etrade2022-bachem&utm_medium=online-EDM&utm_campaign=enedmbachem0420)
Bio Insights:
Cell and Gene Therapy

April 27   4:00 PM UTC+8
Register (https://www.pharmasources.com/zt/etradeseason2022/biopharma?utm_source=etrade2022-bachem&utm_medium=online-EDM&utm_campaign=enedmbachem0420)

Maximize your Awareness by Sponsoring the Webinar!

Innovation and Development of Small Molecule Drugs | May 23-25

Discovery and Early Development of a Novel Core Protein Assembly Modulator for the Treatment of Chronic HBV Infection
Dr. Zhu Wei | Head of Medicinal Chemistry Dept., Roche Innovation Center Shanghai
---------------------------
Target Validation for Parkinson's Disease and Small Molecule Drug Discovery
Dr. Zhou Xianbo | CEO
Zhongze Therapeutics

Check Sponsorship Package (https://efile.imsinoexpo.com/efile/CPhI/edm/E-trade/CPhI%20&%20P-MEC%20China%20E-trade%20Season%202022-0315.pdf?utm_source=etrade2022-bachem&utm_medium=online-EDM&utm_campaign=enpsedmbachem0414)
CPhI & P-MEC China E-Trade Season 2022
Unsubscribe (https://info.cphi-chinaedm.com/x/plugin/?pName=unsubscribe&MIDRID=S7Y1Mf2fa2tsYGJm8D.H1tTA3ML0f5GthaGxsZkBAAA63&Z=141305718)
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.nottingham.ac.uk/pipermail/affymetrix-arabidopsis/attachments/20220421/57fd2784/attachment-0001.html>